- Initial Statement of Beneficial Ownership (3)
March 04 2011 - 6:09AM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Expires:
February 28, 2011
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Li Bing
|
2. Date of Event Requiring Statement (MM/DD/YYYY)
2/27/2011
|
3. Issuer Name
and
Ticker or Trading Symbol
China Biologic Products, Inc. [CBPO]
|
(Last)
(First)
(Middle)
UNIT 2201, BUND CENTER OFFICE TOWER,, NO. 222, YAN-AN ROAD (EAST)
|
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
__
X
__ Director
_____ 10% Owner
_____ Officer (give title below)
_____ Other (specify below)
|
(Street)
SHANGHAI, F4 200002
(City)
(State)
(Zip)
|
5. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security
(Instr. 4)
|
2. Amount of Securities Beneficially Owned
(Instr. 4)
|
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
|
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 4)
|
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
|
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
|
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Non-Qualified Stock Option
(1)
|
2/27/2011
(1)
|
2/27/2021
|
Common Stcok
|
20000
(1)
|
$17.00
|
D
|
|
Explanation of Responses:
|
(
1)
|
On February 27, 2011, the Board of Directors of the Issuer granted to the Reporting Person ten-year non-qualified stock options to purchase 20,000 shares of the Issuer's common stock under the Issuer's 2008 Equity Incentive Plan, pursuant to a stock option agreement, effective as of February 27, 2011, between the Issuer and the Reporting Person. The options have an exercise price of $17.00 and will vest in two equal portions over twelve months, with an initial vesting date of August 27, 2011 and a final vesting date of February 27, 2012.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
Li Bing
UNIT 2201, BUND CENTER OFFICE TOWER,
NO. 222, YAN-AN ROAD (EAST)
SHANGHAI, F4 200002
|
X
|
|
|
|
Signatures
|
/s/ Bing Li
|
|
3/4/2011
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 5(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
China Bioligic Products (NASDAQ:CBPO)
Historical Stock Chart
From Jun 2024 to Jul 2024
China Bioligic Products (NASDAQ:CBPO)
Historical Stock Chart
From Jul 2023 to Jul 2024